| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $68.1M | +26.0% |
| SG&A Expense | $16.6M | +17.0% |
| Operating Income | -$84.8M | -24.1% |
| Pre-tax Income | -$78.6M | -20.1% |
| Income Tax | $73K | -98.0% |
| Net Income | -$78.6M | -13.8% |
| EPS (Basic) | -$3.30 | +25.3% |
| EPS (Diluted) | -$3.30 | +25.3% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $80.8M | -55.6% |
| Short-term Investments | $29.6M | — |
| Current Assets | $112.7M | -39.4% |
| Total Assets | $143.1M | -34.2% |
| Current Liabilities | $17.5M | -6.9% |
| Total Liabilities | $34.6M | -8.4% |
| Stockholders' Equity | $108.4M | -39.6% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$69.0M | -16.4% |
| Capital Expenditures | $2.6M | -30.8% |
| Investing Cash Flow | -$32.0M | -752.3% |
| Financing Cash Flow | -$189K | -100.2% |
| Free Cash Flow | -$71.6M | -13.6% |